FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

The FDA approved a supplemental application to bring ALEVE GELCAPS (naproxen sodium) to market as a new dosage form from Bayer HealthCare LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea
• Gout
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• ALEVE GELCAPS (NAPROXEN SODIUM)

Snippet

SUPPL AP for ALEVE GELCAPS (NAPROXEN SODIUM)